
Cardinal Health (CAH) Stock Forecast & Price Target
Cardinal Health (CAH) Analyst Ratings
Bulls say
Cardinal Health is well-positioned in the pharmaceutical wholesaler market, with a strong national distribution system and strategic partnerships in healthcare technology. Despite a recent impairment, their EPS estimates have been raised and they continue to invest in specialty and biologic therapies, indicating a positive outlook on future growth. Additionally, their focus on ESG performance and value-added services allows them to differentiate themselves in a highly competitive market, further contributing to their strength as a company. Their current valuation may be higher than historical levels, but is justified by their transition into a healthcare services and technology company with a strong presence in nuclear and precision health solutions.
Bears say
Cardinal Health is facing several challenges that could impact its future growth and profitability. These include a potential decrease in margins due to a shift towards specialty pharmaceuticals, potential changes in drug pricing and reimbursement systems, and a potential shift away from the buy-and-bill model in specialty distribution. Other risks for the company include exposure to energy and commodity costs, legal proceedings related to controlled substance distribution, and concentration of revenue from its largest customer, CVS. Despite some potential growth opportunities, such as expansion into specialty services and a strong distribution network, these challenges could hinder Cardinal Health's long-term outlook and competitiveness compared to its peers.
This aggregate rating is based on analysts' research of Cardinal Health and is not a guaranteed prediction by Public.com or investment advice.
Cardinal Health (CAH) Analyst Forecast & Price Prediction
Start investing in Cardinal Health (CAH)
Order type
Buy in
Order amount
Est. shares
0 shares